Viking Therapeutics VKTX Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Viking Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viking Therapeutics's earnings yield?
- Viking Therapeutics (VKTX) reported earnings yield of -12.6% in Q1 2026.
- How has Viking Therapeutics's earnings yield changed year-over-year?
- Viking Therapeutics's earnings yield decreased by 165.5% year-over-year, from -4.7% to -12.6%.
- What is the long-term trend for Viking Therapeutics's earnings yield?
- Over 5 years (2020 to 2025), Viking Therapeutics's earnings yield has grown at a 0.2% compound annual growth rate (CAGR), from -9% to -9%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.